Healthy Male Volunteers

10
Pipeline Programs
8
Companies
50
Clinical Trials
4 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
10
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

8 companies ranked by most advanced pipeline stage

UP
UCB PharmaBelgium - Brussels
3 programs
2
LacosamidePhase 11 trial
UCB0107Phase 11 trial
LacosamideN/A1 trial
Active Trials
NCT01382017Completed18Est. Aug 2012
NCT03086382Completed24Est. Mar 2017
NCT03464227Completed52Est. Dec 2018
Bristol Myers Squibb
2 programs
2
BMS-986165Phase 15 trials
[14C]-BMS-986196Phase 11 trial
Active Trials
NCT04305899Completed40Est. Nov 2020
NCT04249284Completed18Est. Mar 2020
NCT04209699Completed18Est. Feb 2020
+3 more trials
Eli Lilly and Company
Eli Lilly and CompanyINDIANAPOLIS, IN
1 program
1
DrugPhase 15 trials
Active Trials
NCT04603651No Longer Available
NCT05225259No Longer Available
NCT00065312Completed
+2 more trials
E
EisaiChina - Liaoning
1 program
1
E6011Phase 11 trial
Active Trials
NCT01731275Completed64Est. Aug 2013
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
1 program
1
IV methylnaltrexonePhase 11 trial
Active Trials
NCT01367483CompletedEst. Jun 2005
Opko Health
Opko HealthMIAMI, FL
1 program
1
SomatrogonPhase 11 trial
Active Trials
NCT03810664CompletedEst. Apr 2019
Xenon Pharmaceuticals
1 program
1
XPF-008Phase 11 trial
Active Trials
NCT03468725Completed20Est. Jul 2018
PMV Pharma
PMV PharmaPRINCETON, NJ
1 program
1
[14C]-PC14586Phase 11 trial
Active Trials
NCT05523687CompletedEst. Nov 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug
Eli Lilly and CompanyDrug

Showing 15 of 50 trials with date data

Clinical Trials (50)

Total enrollment: 15,088 patients across 50 trials

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

Start: Mar 2026Est. completion: Oct 2027344 patients
Phase 4Not Yet Recruiting

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Start: Mar 2026Est. completion: Dec 2032150 patients
Phase 4Not Yet Recruiting

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

Start: Jun 2025Est. completion: Sep 2026200 patients
Phase 4Recruiting

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Start: May 2025Est. completion: Dec 2032279 patients
Phase 4Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Start: May 2025Est. completion: Dec 2032787 patients
Phase 4Recruiting

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan

Start: Oct 2024Est. completion: Apr 2026130 patients
Phase 4Active Not Recruiting

A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

Start: Apr 2024Est. completion: Jul 202715 patients
Phase 4Active Not Recruiting

A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India

Start: Apr 2024Est. completion: Sep 2025150 patients
Phase 4Completed

A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)

Start: Mar 2023Est. completion: Oct 2023152 patients
Phase 4Completed

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

Start: Aug 2022Est. completion: Nov 2027780 patients
Phase 4Active Not Recruiting

A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis

Start: Mar 2022Est. completion: Nov 202660 patients
Phase 4Active Not Recruiting

A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes

Start: Aug 2021Est. completion: Jun 20220
Phase 4Withdrawn

At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19

Start: Jan 2021Est. completion: Apr 2021139 patients
Phase 4Terminated

A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist

Start: Oct 2020Est. completion: Mar 202165 patients
Phase 4Completed

Anti-CGRP for Inflammation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia

Start: Jul 2020Est. completion: Jan 202326 patients
Phase 4Completed

Taltz in Combination With Enstilar for Psoriasis

Start: Apr 2020Est. completion: Mar 202125 patients
Phase 4Recruiting

A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India

Start: Dec 2019Est. completion: Jul 2021304 patients
Phase 4Completed

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

Start: Apr 2019Est. completion: May 20252,663 patients
Phase 4Completed

A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction

Start: Oct 2014Est. completion: May 2017635 patients
Phase 4Completed

Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes

Start: Feb 2013Est. completion: May 2014325 patients
Phase 4Completed

Comparison of Insulin Mix25 Versus Mix50

Start: Jan 2013Est. completion: Aug 2014403 patients
Phase 4Completed

Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline

Start: Oct 2012Est. completion: Apr 2015641 patients
Phase 4Completed

A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China

Start: Jun 2011Est. completion: Jul 2012383 patients
Phase 4Completed

Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies

Start: Apr 2011Est. completion: Nov 2012478 patients
Phase 4Completed

Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis

Start: Apr 2011Est. completion: Dec 20130
Phase 4Withdrawn

A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus

Start: Feb 2011Est. completion: Nov 2012402 patients
Phase 4Completed

A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects

Start: Dec 2010Est. completion: Mar 2013252 patients
Phase 4Completed

Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

Start: Dec 2010Est. completion: Jan 20131,117 patients
Phase 4Completed

A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes

Start: Oct 2010Est. completion: Feb 201372 patients
Phase 4Completed

A Study in Patients With Erectile Dysfunction

Start: May 2010Est. completion: Jun 2011770 patients
Phase 4Completed

A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients

Start: Sep 2009Est. completion: Apr 2011135 patients
Phase 4Completed

Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes

Start: Oct 2008Est. completion: Oct 201040 patients
Phase 4Completed

Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)

Start: Sep 2008Est. completion: Sep 2010112 patients
Phase 4Completed

Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE

Start: Sep 2008Est. completion: Jun 20097 patients
Phase 4Terminated

Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast

Start: Apr 2008Est. completion: Nov 2010344 patients
Phase 4Completed

Cymbalta for Depression as a Complication of Bereavement

Start: Apr 2008Est. completion: Apr 201020 patients
Phase 4Unknown

A Study for Type 2 Diabetic Patients

Start: Nov 2007Est. completion: Aug 2009426 patients
Phase 4Completed

A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus

Start: May 2007Est. completion: Sep 2007102 patients
Phase 4Completed

A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine

Start: Apr 2007Est. completion: Nov 2008228 patients
Phase 4Completed

A Study for Patients With Diabetes Mellitus (IOPA)

Start: Jan 2007Est. completion: Jan 2008117 patients
Phase 4Completed

Medication, Weight Gain and GI Hormones

Start: Jan 2007Est. completion: Mar 201020 patients
Phase 4Completed

Insulin Therapy in the Hospital Comparing Two Protocols

Start: Dec 2006Est. completion: Jun 200960 patients
Phase 4Completed

Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)

Start: Oct 2006Est. completion: Mar 2009302 patients
Phase 4Completed

Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics

Start: Sep 2006Est. completion: Jun 200825 patients
Phase 4Completed

The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes

Start: Aug 2006Est. completion: Sep 201072 patients
Phase 4Completed

Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)

Start: Aug 2006Est. completion: Sep 2008484 patients
Phase 4Completed

Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL

Start: Jun 2006Est. completion: Dec 20071 patients
Phase 4Terminated

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Start: May 2006Est. completion: Dec 2007628 patients
Phase 4Completed

Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)

Start: Mar 2006Est. completion: Dec 2007149 patients
Phase 4Completed

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Start: Dec 2005Est. completion: Sep 201569 patients
Phase 4Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 actively recruiting trials targeting 15,088 patients
8 companies competing in this space